The largest meta-analysis of 2,472 ADHD patients from 38 randomized controlled trials of neuro feedback was just published in JAMA. Unfortunately, the overall data “did not appear to meaningfully benefit with neurofeedback in individuals with ADHD, clinically or neuropsychologically, at the group level.”

A total of 38 RCTs (2472 participants aged 5 to 40 years) were included.

Read article: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2827733 

With an aging population and under recognition of ADHD in older adults, we are missing the opportunity to effectively treat these individuals.

Read article: https://www.nytimes.com/2024/12/11/well/mind/adhd-diagnosis-older-middle-age.html?smid=nytcore-android-share